Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients

Gastroenterology

Volumn 128, Issue 3, 2005, Pages 636-641

  Romero Gómez, Manuel ^a   Del Mar Viloria, Maria ^a   Andrade, Raúl J ^b   Salmerón, Javier ^c   Diago, Moisés ^d   Fernández Rodríguez, Conrado M ^e   Corpas, Raquel ^a   Cruz, Marina ^a   Grande, Lourdes ^a   Vázquez, Luis ^b   Muñoz De Rueda, Paloma ^c   López Serrano, Pilar ^e   Gila, Ana ^c   Gutiérrez, María L ^e   Pérez, Celia ^d   Ruiz Extremera, Angela ^c   Suárez, Emilio ^a   Castillo, Jesús ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^e HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON; RIBAVIRIN; ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALFA-2A; PEGINTERFERON ALFA-2B; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B;

ADULT; AGE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC HEPATITIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG RESPONSE; FATTY LIVER; FEMALE; GENDER; GENOTYPE; HEPATITIS C; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VIRUS LOAD; AGED; COHORT ANALYSIS; DRUG COMBINATION; LIVER CIRRHOSIS; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME; VIREMIA; VIROLOGY;

ADULT; AGED; ANTIVIRAL AGENTS; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; INSULIN RESISTANCE; INTERFERON ALFA-2A; INTERFERON ALFA-2B; LIVER CIRRHOSIS; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN; TREATMENT OUTCOME; VIRAL LOAD; VIREMIA;

EID: 15744381704     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.12.049     Document Type: Article

References (28)

1. M.W. Fried, M.L. Shiffman, K.R. Reddy, C. Smith, G. Marinos, F.L. Goncales Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 2002 975 982
2. M. Romero-Gomez, M.F. Gonzalez-Escribano, B. Torres, N. Barroso, M.A. Montes-Cano, D. Sanchez-Munoz HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C Am J Gastroenterol 98 2003 1621 1626
3. H. Sim, J. Wojcik, M. Margulies, J.A. Wade, J. Heathcote Response to interferon therapy Influence of human leucocyte antigen alleles in patients with chronic hepatitis C J Viral Hepat 5 1998 249 253
4. J.L. Kinzie, P.H. Naylor, M.G. Nathani, R.R. Peleman, M.N. Ehrinpreis, M. Lybik African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians J Viral Hepat 8 2001 264 269
5. B.L. Bressler, M. Guindi, G. Tomlinson, J. Heathcote High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C Hepatology 38 2003 639 644
6. M.P. Civeira, J. Prieto Early predictors of response to treatment in patients with chronic hepatitis C J Hepatol 31 Suppl 1 1999 237 243
7. A.J. Muir, J.D. Bornstein, P.G. Killenberg Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites N Engl J Med 350 2004 2265 2271
8. Y. Shintani, H. Fujie, H. Miyoshi, T. Tsutsumi, K. Tsukamoto, S. Kimura Hepatitis C virus infection and diabetes direct involvement of the virus in the development of insulin resistance Gastroenterology 126 2004 840 848
9. J.M. Hui, A. Sud, G.C. Farrell, P. Bandara, K. Byth, J.G. Kench Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression Gastroenterology 125 2003 1695 1704
10. A. Lonardo, L.E. Adinolfi, P. Loria, N. Carulli, G. Ruggiero, C.P. Day Steatosis and hepatitis C virus mechanisms and significance for hepatic and extrahepatic disease Gastroenterology 126 2004 586 597
11. J.M. Petit, J.B. Bour, C. Galland-Jos, A. Minello, B. Verges, M. Guiguet Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C J Hepatol 35 2001 279 283
12. E. Bonora, G. Formentini, F. Calcaterra, S. Lombardi, F. Marini, L. Zenari HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects prospective data from the Verona Diabetes Complications Study Diabetes Care 25 2002 1135 1141
13. S.A. Chang, H.S. Kim, K.H. Yoon, S.H. Ko, H.S. Kwon, S.R. Kim Body mass index is the most important determining factor for the degree of insulin resistance in non-obese type 2 diabetic patients in Korea Metabolism 53 2004 142 146
14. A. Misra Impact of ethnicity on body fat patterning in Asian Indians and blacks relation with insulin resistance Nutrition 19 2003 815 816
15. M. Duong, J.M. Petit, L. Piroth, M. Grappin, M. Buisson, P. Chavanet Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy J Acquir Immune Defic Syndr 27 2001 245 250
16. H.M. Patton, K. Patel, C. Behling, D. Bylund, L.M. Blatt, M. Vallee The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients J Hepatol 40 2004 484 490
17. V.A. Koivisto, R. Pelkonen, K. Cantell Effect of interferon on glucose tolerance and insulin sensitivity Diabetes 38 1989 641 647
18. E. Imano, T. Kanda, Y. Ishigami, M. Kubota, M. Ikeda, M. Matsuhisa Interferon induces insulin resistance in patients with chronic active hepatitis C J Hepatol 28 1998 189 193
19. Y. Ito, N. Takeda, M. Ishimori, A. Akai, K. Miura, K. Yasuda Effects of long-term interferon-alpha treatment on glucose tolerance in patients with chronic hepatitis C J Hepatol 31 1999 215 220
20. T.Y. Tai, J.Y. Lu, C.L. Chen, M.Y. Lai, P.J. Chen, J.H. Kao Interferon-alpha reduces insulin resistance and beta-cell secretion in responders among patients with chronic hepatitis B and C J Endocrinol 178 2003 457 465
21. H. Knobler, T. Zhornicky, A. Sandler, N. Haran, Y. Ashur, A. Schattner Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association Am J Gastroenterol 98 2003 2751 2756
22. T. Maeno, A. Okumura, T. Ishikawa, K. Kato, F. Sakakibara, K. Sato Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection J Gastroenterol Hepatol 18 2003 1358 1363
23. E. Larrea, N. Garcia, C. Qian, M.P. Civeira, J. Prieto Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C Hepatology 23 1996 210 217
24. S. Aytug, D. Reich, L.E. Sapiro, D. Bernstein, N. Begum Impaired IRS-1/PI3-kinase signalling in patients with HCV a mechanism for increased prevalence of type 2 diabetes Hepatology 38 2003 1384 1392
25. H. Tanaka, G. Shiota, H. Kawasaki Changes in glucose tolerance after interferon-alpha therapy in patients with chronic hepatitis C J Med 28 1997 335 346
26. M. Naeem, B.R. Bacon, B. Mistry, R.S. Britton, A.M. Di Bisceglie Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C Am J Gastroenterol 96 2001 2468 2472
27. R. Bataller, Y.H. Paik, J.N. Lindquist, J.J. Lemasters, D.A. Brenner Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells Gastroenterology 126 2004 529 540
28. M. Romero-Gomez, V.M. Castellano-Megias, L. Grande, J.A. Irles, M. Cruz, M.C. Nogales Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C Am J Gastroenterol 98 2003 1135 1141